Russell Investments Group Ltd. Purchases Shares of 491 Hawkins, Inc. $HWKN

Russell Investments Group Ltd. bought a new position in Hawkins, Inc. (NASDAQ:HWKNFree Report) during the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm bought 491 shares of the specialty chemicals company’s stock, valued at approximately $52,000.

Several other hedge funds also recently made changes to their positions in the company. Vermillion Wealth Management Inc. bought a new stake in Hawkins in the fourth quarter valued at $34,000. Whittier Trust Co. of Nevada Inc. boosted its holdings in Hawkins by 118.8% in the first quarter. Whittier Trust Co. of Nevada Inc. now owns 280 shares of the specialty chemicals company’s stock valued at $30,000 after acquiring an additional 152 shares in the last quarter. GAMMA Investing LLC boosted its holdings in Hawkins by 20.4% in the first quarter. GAMMA Investing LLC now owns 531 shares of the specialty chemicals company’s stock valued at $56,000 after acquiring an additional 90 shares in the last quarter. Whittier Trust Co. boosted its holdings in Hawkins by 101.3% in the first quarter. Whittier Trust Co. now owns 614 shares of the specialty chemicals company’s stock valued at $65,000 after acquiring an additional 309 shares in the last quarter. Finally, TD Private Client Wealth LLC boosted its holdings in Hawkins by 40.0% in the first quarter. TD Private Client Wealth LLC now owns 661 shares of the specialty chemicals company’s stock valued at $70,000 after acquiring an additional 189 shares in the last quarter. 69.71% of the stock is owned by hedge funds and other institutional investors.

Hawkins Trading Up 1.2%

Shares of NASDAQ:HWKN opened at $168.69 on Friday. The business’s 50 day moving average price is $163.49 and its 200-day moving average price is $134.26. Hawkins, Inc. has a 1 year low of $98.30 and a 1 year high of $185.50. The company has a debt-to-equity ratio of 0.59, a current ratio of 2.31 and a quick ratio of 1.45. The firm has a market capitalization of $3.52 billion, a price-to-earnings ratio of 41.55, a price-to-earnings-growth ratio of 2.36 and a beta of 0.86.

Hawkins (NASDAQ:HWKNGet Free Report) last issued its earnings results on Wednesday, July 30th. The specialty chemicals company reported $1.40 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.33 by $0.07. The business had revenue of $293.27 million during the quarter, compared to the consensus estimate of $278.76 million. Hawkins had a return on equity of 18.35% and a net margin of 8.37%. On average, equities research analysts forecast that Hawkins, Inc. will post 4 earnings per share for the current fiscal year.

Hawkins Increases Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, August 29th. Investors of record on Friday, August 15th were paid a dividend of $0.19 per share. The ex-dividend date was Friday, August 15th. This is a positive change from Hawkins’s previous quarterly dividend of $0.18. This represents a $0.76 annualized dividend and a yield of 0.5%. Hawkins’s dividend payout ratio (DPR) is presently 18.72%.

Wall Street Analysts Forecast Growth

A number of analysts have recently weighed in on HWKN shares. BWS Financial upped their target price on shares of Hawkins from $160.00 to $200.00 and gave the stock a “buy” rating in a research report on Friday, August 1st. Raymond James Financial started coverage on shares of Hawkins in a report on Thursday, July 24th. They set a “market perform” rating for the company. Wall Street Zen downgraded Hawkins from a “buy” rating to a “hold” rating in a research report on Saturday, July 5th. Finally, Zacks Research upgraded Hawkins to a “strong-buy” rating in a research report on Tuesday, August 12th. One analyst has rated the stock with a Strong Buy rating, two have assigned a Buy rating and one has assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, Hawkins currently has an average rating of “Buy” and a consensus price target of $162.50.

Get Our Latest Research Report on HWKN

About Hawkins

(Free Report)

Hawkins, Inc operates as a specialty chemical and ingredients company in the United States. It operates through three segments: Industrial, Water Treatment, and Health and Nutrition. The Industrial segment offers industrial chemicals, products, and services to agriculture, chemical processing, electronics, energy, food, pharmaceutical, and plating industries.

Recommended Stories

Want to see what other hedge funds are holding HWKN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Hawkins, Inc. (NASDAQ:HWKNFree Report).

Institutional Ownership by Quarter for Hawkins (NASDAQ:HWKN)

Receive News & Ratings for Hawkins Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hawkins and related companies with MarketBeat.com's FREE daily email newsletter.